Universitaetsklinikum Tuebingen AöR
- Address
- Otfried-Mueller-Strasse 10, Nordstadt
Sponsor Overview
Specializations
Hematology and Cell Therapy
Clinical research includes acute myeloid leukemia, myelodysplastic neoplasms, chronic lymphocytic leukemia, lymphoma, and acute lymphoblastic leukemia, with activity across relapsed, refractory, and post-transplant settings.
- Allogeneic stem cell transplantation
- B-cell malignancies
- Minimal residual disease
- Leukemia vaccination
Research also covers fusion-driven sarcomas, fibrolamellar hepatocellular carcinoma, and immunotherapy-based approaches in advanced blood cancers and solid tumors.
Neuro-oncology and Neurology
Trials address glioblastoma, leptomeningeal disease, Parkinson disease, and disorders of brain injury and impaired vigilance, including hypoxic-ischemic encephalopathy and unresponsive wakefulness syndrome.
- Intrathecal immunotherapy
- Dopaminergic symptom control
- Neurorecovery
- Consciousness impairment
Additional work includes treatment strategies for chronic depression and neurological complications associated with severe illness.
Ophthalmology and Inherited Retinal Disease
Research activity includes acute central retinal artery occlusion, retinopathy of prematurity, achromatopsia, and retinitis pigmentosa, spanning both acquired and genetic causes of vision loss.
- Retinal ischemia
- Gene therapy
- Prematurity-related eye disease
- Visual function recovery
The portfolio reflects interest in restoring or preserving retinal function in paediatric and adult populations.
Pediatric, Neonatal, and Respiratory Care
Trials focus on extremely preterm infants, prematurity complications, and neonatal outcomes after asphyxia, with attention to respiratory support and neurodevelopment.
- Mechanical ventilation
- Therapeutic hypothermia
- Neurodevelopmental impairment
- Retinopathy of prematurity
Research also includes prevention and management of neonatal complications in intensive care settings.
Oncology, Metabolic Disease, and Infectious Disease
Studies extend to prostate cancer, rectal cancer, melanoma, and prediabetes, alongside work in malaria, COVID-19, and Staphylococcus aureus colonization.
- PSMA-targeted therapy
- Radiochemotherapy
- Glucose metabolism
- Vaccine immunogenicity
These trials encompass both cancer-directed treatment and prevention-oriented research in infectious and metabolic conditions.
Sponsored Trials
Data & Insights
This sponsor works with 30 molecules, of which 7 are not being studied by other sponsors.
This sponsor has worked with 61 sites across their trial portfolio.
Therapeutic Focus
- 1.Neoplasms5 trials853 other sponsors
- 2.Hemic and Lymphatic Diseases4 trials249 other sponsors
- 3.Nervous System Diseases4 trials449 other sponsors
- 4.Congenital, Hereditary, and Neonatal Diseases and Abnormalities3 trials165 other sponsors
- 5.Eye Diseases3 trials138 other sponsors
- 6.Male Urogenital Diseases3 trials111 other sponsors
- 7.Bacterial Infections and Mycoses2 trials180 other sponsors
- 8.Digestive System Diseases2 trials280 other sponsors
- 9.Parasitic Diseases2 trials9 other sponsors
- 10.Mental Disorders1 trial150 other sponsors
- 11.Not possible to specify1 trial220 other sponsors
- 12.Nutritional and Metabolic Diseases1 trial211 other sponsors
- 13.Skin and Connective Tissue Diseases1 trial247 other sponsors
- 14.Virus Diseases1 trial182 other sponsors
Partnered Research Centres
61 centres- Address
- Via Filippo Corridoni 11, 60123 Ancona
- Address
- Bernhard-Nocht-Straße 74, St. Pauli, 20359 Hamburg
- Address
- 4 Rue Nicolas-Ernest Barble, 1210 Luxembourg
- Address
- Boulevard Du Douzieme De Ligne 1, 4000 Liège
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- Auf'm Hennekamp 65, Nordrhein-Westfalen, 40225 Düsseldorf
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Universitaetsklinikum Tuebingen AöR.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.